Barć, P.; Antkiewicz, M.; Frączkowska-Sioma, K.; Kupczyńska, D.; Lubieniecki, P.; Witkiewicz, W.; Małodobra-Mazur, M.; Baczyńska, D.; Janczak, D.; Skóra, J.P.
Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome. Int. J. Environ. Res. Public Health 2022, 19, 12818.
https://doi.org/10.3390/ijerph191912818
AMA Style
Barć P, Antkiewicz M, Frączkowska-Sioma K, Kupczyńska D, Lubieniecki P, Witkiewicz W, Małodobra-Mazur M, Baczyńska D, Janczak D, Skóra JP.
Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome. International Journal of Environmental Research and Public Health. 2022; 19(19):12818.
https://doi.org/10.3390/ijerph191912818
Chicago/Turabian Style
Barć, Piotr, Maciej Antkiewicz, Katarzyna Frączkowska-Sioma, Diana Kupczyńska, Paweł Lubieniecki, Wojciech Witkiewicz, Małgorzata Małodobra-Mazur, Dagmara Baczyńska, Dariusz Janczak, and Jan Paweł Skóra.
2022. "Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome" International Journal of Environmental Research and Public Health 19, no. 19: 12818.
https://doi.org/10.3390/ijerph191912818
APA Style
Barć, P., Antkiewicz, M., Frączkowska-Sioma, K., Kupczyńska, D., Lubieniecki, P., Witkiewicz, W., Małodobra-Mazur, M., Baczyńska, D., Janczak, D., & Skóra, J. P.
(2022). Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome. International Journal of Environmental Research and Public Health, 19(19), 12818.
https://doi.org/10.3390/ijerph191912818
